secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dyne Therapeutics, Inc. (DYN)
CIK:        0001818794
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0000950170-25-082317
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Dyne Therapeutics shareholders elect Hurwitz, Kersten; approve say-on-pay
-------------------------------------------------------------------------

- Edward Hurwitz elected with 62.9M votes for, 27.4M withheld; Dirk Kersten with 58.3M for, 32.0M withheld.
- Non-binding advisory say-on-pay approved: 74.4M for, 15.8M against, 81.6K abstain.
- Stockholders recommend advisory vote on executive compensation every year (90.2M votes); company will hold annual say-on-pay.
- Ratification of Deloitte & Touche LLP as independent auditor for FY2025: 105.6M for, 19.8K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818794/000095017025082317/0000950170-25-082317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818794/000095017025082317/dyn-20250530.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-082317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer